- Home
- OBIO vs ULBI Comparison
OBIO vs ULBI Comparison
Compare OBIO & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ULBI
- Stock Information
- Founded
- OBIO 2017
- ULBI 1990
- Country
- OBIO United States
- ULBI United States
- Employees
- OBIO N/A
- ULBI N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ULBI Industrial Machinery/Components
- Sector
- OBIO Health Care
- ULBI Miscellaneous
- Exchange
- OBIO Nasdaq
- ULBI Nasdaq
- Market Cap
- OBIO 118.8M
- ULBI 128.6M
- IPO Year
- OBIO N/A
- ULBI 1992
- Fundamental
- Price
- OBIO $2.57
- ULBI $6.51
- Analyst Decision
- OBIO Strong Buy
- ULBI Strong Buy
- Analyst Count
- OBIO 4
- ULBI 1
- Target Price
- OBIO $14.00
- ULBI $14.00
- AVG Volume (30 Days)
- OBIO 403.6K
- ULBI 62.9K
- Earning Date
- OBIO 08-12-2025
- ULBI 08-07-2025
- Dividend Yield
- OBIO N/A
- ULBI N/A
- EPS Growth
- OBIO N/A
- ULBI N/A
- EPS
- OBIO N/A
- ULBI 0.19
- Revenue
- OBIO $2,944,000.00
- ULBI $178,853,000.00
- Revenue This Year
- OBIO $20.47
- ULBI $31.30
- Revenue Next Year
- OBIO $11.45
- ULBI $6.24
- P/E Ratio
- OBIO N/A
- ULBI $33.88
- Revenue Growth
- OBIO 41.61
- ULBI 5.86
- 52 Week Low
- OBIO $2.37
- ULBI $4.07
- 52 Week High
- OBIO $7.04
- ULBI $11.48
- Technical
- Relative Strength Index (RSI)
- OBIO 40.46
- ULBI 29.47
- Support Level
- OBIO $2.50
- ULBI $6.24
- Resistance Level
- OBIO $2.75
- ULBI $6.93
- Average True Range (ATR)
- OBIO 0.18
- ULBI 0.45
- MACD
- OBIO -0.03
- ULBI -0.19
- Stochastic Oscillator
- OBIO 11.47
- ULBI 10.31
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.